Michael Esber, DPM
NPI 1174597462 · Foot & Ankle Surgery Podiatrist · Sun City West, AZ
Enrolled with Medicare as Practitioner - Podiatry · source: CMS PECOS Public Provider Enrollment (2026.04.01)
Provider details
- NPI number
- 1174597462
- Entity type
- Individual
- Primary specialty
- Foot & Ankle Surgery PodiatristPodiatric Medicine & Surgery Service Providers
- Credential
- DPM
- Sex
- Male
- Sole proprietor
- No
- License
- DPM 358 (AZ)
Specialties & taxonomies
Podiatric Medicine & Surgery Service Providers
Profile Score
A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.
- Registry tenure25% of score
20 yrs in NPPES registry
- Profile completeness25% of score
100% of core fields populated
- Practice footprint15% of score
1 documented practice location
- Medicare service volume (vs. specialty peers)25% of score
1,378 Medicare services, 2024 (ranked within specialty)
- Open Payments transparency10% of score
Has Open Payments disclosures (2024)
Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our .
What this provider does (Medicare)
Based on Medicare fee-for-service claims, 2024; not all care is captured.
| Service (HCPCS) | Medicare services | Typical Medicare-allowed (2024) |
|---|---|---|
| Removal of Fingernails Or Toenails, 6 Or More Nails11721 | 283 | $43 |
| Established Patient Office Or Other Outpatient Visit With Low Level OD Decision Making, If Using Time, 20 Minutes Or More99213 | 258 | $87 |
| Removal of Noncancer Thickened Skin Growth, 2-4 Growths11056 | 145 | $79 |
| X-Ray of Foot, Minimum of 3 Views73630 | 130 | $33 |
| Removal of Noncancer Thickened Skin Growth, More Than 4 Growths11057 | 81 | $86 |
| Removal of Skin and Tissue, 20.0 Sq Cm Or Less11042 | 73 | $125 |
What this provider prescribes (Medicare Part D)
Top drugs by Medicare Part D claim volume, 2024 · 10 distinct drugs on file.
| Drug | Part D claims (2024) | Beneficiaries |
|---|---|---|
| Mupirocin | 202 | 170 |
| Doxycycline Hyclate | 86 | 70 |
| Clotrimazole | 81 | 64 |
| Meloxicam | 61 | 44 |
| Gentamicin Sulfate | 49 | 40 |
| Clobetasol Propionate | 35 | 25 |
| Methylprednisolone | 30 | 28 |
| Cephalexin | 24 | 23 |
Transparency — industry payments
Based on CMS Open Payments, 2024; not all care is captured.
$856 across 27 records (Open Payments 2024)
Open Payments discloses payments and transfers of value (meals, travel, consulting, research, royalties) from drug and device makers to providers. This is a transparency signal, not a verdict — such payments are legal and common, and their presence is neither an endorsement nor a criticism. Source: CMS Open Payments, program year 2024.
Practice location
Mailing address
Registry dates
- Enumerated
- 2006-02-14
- Last updated
- 2007-07-08
Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.